Barr's Duramed Exec Ben-Maimon Plans Departure
This article was originally published in The Pink Sheet Daily
Executive Summary
Carole Ben-Maimon presented Barr's Plan B Rx-to-OTC switch application to FDA's Nonprescription Drugs and Reproductive Health Drugs advisory committees.